FDA Approval Letter Abilify MyCite (aripiprazole)

FDA Approval Letter Abilify MyCite (aripiprazole)


Publication/Creation Date
November 13 2017
Creators/Contributors
Food And Drug Administration (FDA) (creator)
Otsuka Pharmaceutical (contributor)
Persuasive Intent
Information
Description
Approval letter for Abilify MyCite digital pill with sensor from United States Food & Drug Administration
HCI Platform
Ingestible
Relation to Body
In
Related Body Part
Digestive Tract
Source
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/207202Orig1s000Approv.pdf

Date archived
October 5 2021
Last edited
October 5 2021
How to cite this entry
Food and Drug Administration (FDA). (November 13 2017). "FDA Approval Letter Abilify MyCite (aripiprazole)". The Center for Drug Evaluation and Research. Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/5477